Trending...
- City Of Boston Licensing Board Approves 21 New Liquor Licenses
- Mayor Wu Appoints New Commissioners To Boston Civic Design Commission
- City of Boston Licensing Board Approves 21 New Liquor Licences
At-Home STI diagnostic technology has the potential to transform sexual health and women's healthcare in the US
BOSTON - BostonChron -- Quarksen (https://www.quarksen.com/) Inc., an innovator in sensing technology, is proud to announce that it has been awarded a U.S. National Science Foundation (NSF) Small Business Innovation Research (SBIR) Phase I grant. The grant will advance the development of eQuanta™ - Quarksen's groundbreaking sensing platform, with potential to deliver accessible, accurate, and rapid STI testing.
The NSF SBIR Phase I grant will fund ongoing research and development of eQuanta™, which has potential to offer an at-home STI testing experience. Leveraging cutting-edge graphene technology, eQuanta™ has potential to deliver highly sensitive, specific, and nearly instantaneous detection of STIs.
"Receiving an NSF SBIR Phase I grant demonstrates the potential of our technology," said Shadi Emam, Founder and Chief Technology Officer of Quarksen. "We envision eQuanta™ advancing STI diagnostics by empowering patients with an accessible, accurate, and rapid at-home STI diagnostic solution. This funding will accelerate our development and bring us one step closer to transforming STI diagnostics."
More on Boston Chron
STIs are a significant American public health issue
In 2018, CDC reported more than 26 million new cases of STIs representing close to $16 billion in total lifetime medical costs.
eQuanta™
Unlike other STI tests that require patients to travel to clinics or ship their samples, eQuanta™ has potential to provide an at-home experience.
Quarksen's vision – advancing diagnostics in sexual health, women's health, and beyond
"STIs are the first frontier in our mission to transform healthcare," said Dr. Zohreh Izadifar, Co-Founder and Chief Scientific Officer of Quarksen. "We envision multiple applications of eQuanta's™ unique technology to empower patients and healthcare providers with accessible, accurate, and rapid diagnostic information."
CAUTION - Investigational Device. Limited by Federal (or United States) law to investigational use
About Quarksen
Founded by Drs. Shadi Emam and Zohreh Izadifar, Quarksen is innovating eQuanta™ to tranform diagnostics.
More on Boston Chron
About the NSF's Small Business Programs
America's Seed Fund powered by NSF awards $200 million annually to startups and small businesses, transforming scientific discovery into products and services with commercial and societal impact. Startups working across almost all areas of science and technology can receive up to $2 million to support research and development (R&D), helping de-risk technology for commercial success. America's Seed Fund is congressionally mandated through the Small Business Innovation Research (SBIR) program. The NSF is an independent federal agency with a budget of about $9 billion that supports fundamental research and education across all fields of science and engineering. For more information, visit seedfund.nsf.gov.
The NSF SBIR Phase I grant will fund ongoing research and development of eQuanta™, which has potential to offer an at-home STI testing experience. Leveraging cutting-edge graphene technology, eQuanta™ has potential to deliver highly sensitive, specific, and nearly instantaneous detection of STIs.
"Receiving an NSF SBIR Phase I grant demonstrates the potential of our technology," said Shadi Emam, Founder and Chief Technology Officer of Quarksen. "We envision eQuanta™ advancing STI diagnostics by empowering patients with an accessible, accurate, and rapid at-home STI diagnostic solution. This funding will accelerate our development and bring us one step closer to transforming STI diagnostics."
More on Boston Chron
- SacraPod Suites Unveils AI-Powered 'Work + Rest' Smart Hospitality Model for Retrofitting Underused Motels Across the U.S
- From Real Estate to Reel Power: H.L Woods Carves His Legacy as a Cutting-Edge Visionary Filmmaker
- New Release: 'The Invisible Alternative' Unveiled by Atrisk Corporation, Resilient
- Mikel DeFrancesco Named RealTrends Top Realtor in Quincy, Milton & South Shore MA
- Cynthia Pinot Among Artists Selected for Renowned London Art Biennale 2025
STIs are a significant American public health issue
In 2018, CDC reported more than 26 million new cases of STIs representing close to $16 billion in total lifetime medical costs.
eQuanta™
Unlike other STI tests that require patients to travel to clinics or ship their samples, eQuanta™ has potential to provide an at-home experience.
Quarksen's vision – advancing diagnostics in sexual health, women's health, and beyond
"STIs are the first frontier in our mission to transform healthcare," said Dr. Zohreh Izadifar, Co-Founder and Chief Scientific Officer of Quarksen. "We envision multiple applications of eQuanta's™ unique technology to empower patients and healthcare providers with accessible, accurate, and rapid diagnostic information."
CAUTION - Investigational Device. Limited by Federal (or United States) law to investigational use
About Quarksen
Founded by Drs. Shadi Emam and Zohreh Izadifar, Quarksen is innovating eQuanta™ to tranform diagnostics.
More on Boston Chron
- Real Estate Experts Highlight Jersey Shore as a Smart Buy in 2025
- Verdane Invests in Guardsquare to Scale Mobile Security Solutions for All Businesses
- Holland America Line Marks America's 250th Anniversary in 2026 with Cruise to Historical U.S. Ports
- $18 Price Target Issued in New Research Report After $34 Million Revenue Forecast from Acquisition; $101.5 Million Net Revenue in 2025; NAS DAQ: IQST
- West Dentistry Welcomes New Oral Surgeon to Enhance Patient Care
About the NSF's Small Business Programs
America's Seed Fund powered by NSF awards $200 million annually to startups and small businesses, transforming scientific discovery into products and services with commercial and societal impact. Startups working across almost all areas of science and technology can receive up to $2 million to support research and development (R&D), helping de-risk technology for commercial success. America's Seed Fund is congressionally mandated through the Small Business Innovation Research (SBIR) program. The NSF is an independent federal agency with a budget of about $9 billion that supports fundamental research and education across all fields of science and engineering. For more information, visit seedfund.nsf.gov.
Source: Quarksen
0 Comments
Latest on Boston Chron
- Get Your Cowboy Boots On! Causeway Country BBQ Music Festival Kicks Off September 12–14 in Ft. Pierce
- Retired Hobbyist Launches Bold Weekly Album Project Using AI Songwriting Tools
- DimHum Launches Revolutionary CrowdShipping Service
- Eolian Signs New Information Exchange Agreement with the U.S. Department of Defense for Technology Innovation
- Infinite Health Introduces Cutting-Edge Regenerative Medicine for Wound Care with Trip Goolsby, MD
- Boston: Mayor Wu Announces Second Year of City-wide Participatory Budgeting Initiative
- Top Dentist Concord CA, Smile Makers Dental Care, Celebrates 500 5-Star Reviews
- Bio-Inspired Technology-Dynamic and Adaptable for unknown real-world environments
- City Of Boston Licensing Board Approves 21 New Liquor Licenses
- New Report Highlights Increasing Demand for Technology-Driven Solutions Across the Real Estate Market
- The Atlantic Resilency Innovation Institute Deploys First Coastal Sensor for Emergency Response
- Boston: Mayor Wu Joins Federal and State Leaders to Celebrate Start of the Mary Ellen McCormack Public Housing Redevelopment Construction
- Michael Reafsnyder opens solo exhibition at Scott Richards Contemporary Art in San Francisco
- City of Boston Licensing Board Approves 21 New Liquor Licences
- Boston: Mayor Michelle Wu Joins Federal and State Leaders to Celebrate the Start of Construction of the Redevelopment of the Mary Ellen McCormack Public Housing
- Mayor Wu Appoints New Commissioners To Boston Civic Design Commission
- Valley Sleep Therapy Expands to Prescott with New Location at Crossings Road
- $17.4 Million Total Revenue for First Half of 2025 (up 31.8% YOY) for Global Wet Trades Services Provider with High Value Bitcoin Investments
- $12.8 Million Net Revenue for 2024 for Cloud-Based Crowdsourcing Recruitment and SaaS-Enabled HR Solutions Provider: Baiya International Group Inc
- Boston: Community, Personal Fitness, and Social Wellness in July